shutterstock_2180131035_jhvephoto

JHVEPhoto / Shutterstock.com

13 July 2023Big PharmaMarisa Woutersen

Illumina fined record €432m for completing Grail merger before EC approval

Commission says dealmakers ‘knowingly and intentionally’ breached standstill obligation | Grail receives the first-ever fine for a target company under EU merger rules.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

BGI wins $333m in DNA patent suit with Illumina

9 May 2022 Illumina has been ordered to pay more than $333 million to Chinese sequencing company MGI—a subsidiary of BGI Group formally known as Complete Genomics—following a jury ruling that Illumina infringed two of its DNA-sequencing patents.

Scientist accuses Illumina of long-running trade secrets plot

11 April 2023 Dispute stems from the theft of a data set of ZipCode sequences used in genetic testing | Plaintiff holds that pharma companies conspired against him | Cornell University claimed Thermo Fisher had misled it into settling a lawsuit in 2017.

More on this story

BGI wins $333m in DNA patent suit with Illumina

9 May 2022 Illumina has been ordered to pay more than $333 million to Chinese sequencing company MGI—a subsidiary of BGI Group formally known as Complete Genomics—following a jury ruling that Illumina infringed two of its DNA-sequencing patents.

Scientist accuses Illumina of long-running trade secrets plot

11 April 2023 Dispute stems from the theft of a data set of ZipCode sequences used in genetic testing | Plaintiff holds that pharma companies conspired against him | Cornell University claimed Thermo Fisher had misled it into settling a lawsuit in 2017.

More on this story

BGI wins $333m in DNA patent suit with Illumina

9 May 2022 Illumina has been ordered to pay more than $333 million to Chinese sequencing company MGI—a subsidiary of BGI Group formally known as Complete Genomics—following a jury ruling that Illumina infringed two of its DNA-sequencing patents.

Scientist accuses Illumina of long-running trade secrets plot

11 April 2023 Dispute stems from the theft of a data set of ZipCode sequences used in genetic testing | Plaintiff holds that pharma companies conspired against him | Cornell University claimed Thermo Fisher had misled it into settling a lawsuit in 2017.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB

Lewis Roca promotes tech expert to managing partner

Panitch Schwarze brings in molecular biologist

US targets ‘product hopping’ with biologic litigation curbs

UPC confirms validity of Edwards Lifesciences heart valve tech patent

ITC concludes row over biotech lab equipment between US and German rivals

UKIPO launches ‘revolutionary’ patent filing and AI tool

USPTO clarifies AI's role in patent eligibility